Abano Healthcare Group Limited provided earnings guidance for the year ending May 31, 2017. For the year, the company expects gross revenue to be in the in the range of $277 million to $281 million, revenue to be $231 million to $235 million, EBITDA to be $30.7 million to $31.9 million, Underlying EBITDA to be $31.5 million to $32.7 million, NPAT to be $9.7 million to $10.5 million, Underlying NPAT to be $10.7 million to $11.5 million.